MaxCyte, Inc. (MXCT)
1.225
+0.04
(+2.94%)
USD |
NASDAQ |
Sep 21, 16:00
1.225
0.00 (0.00%)
After-Hours: 20:00
MaxCyte Enterprise Value : 37.86M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 37.86M |
| September 17, 2026 | 38.39M |
| September 16, 2026 | 36.80M |
| September 15, 2026 | 37.86M |
| September 14, 2026 | 36.27M |
| September 11, 2026 | 34.68M |
| September 10, 2026 | 37.86M |
| September 09, 2026 | 41.04M |
| September 08, 2026 | 46.88M |
| September 04, 2026 | 47.41M |
| September 03, 2026 | 45.29M |
| September 02, 2026 | 46.35M |
| September 01, 2026 | 43.17M |
| August 31, 2026 | 48.47M |
| August 28, 2026 | 41.04M |
| August 27, 2026 | 47.41M |
| August 26, 2026 | 50.60M |
| August 25, 2026 | 54.84M |
| August 24, 2026 | 59.09M |
| August 21, 2026 | 58.03M |
| August 20, 2026 | 58.03M |
| August 19, 2026 | 59.09M |
| August 18, 2026 | 46.35M |
| August 17, 2026 | 51.66M |
| August 14, 2026 | 51.66M |
| Date | Value |
|---|---|
| August 13, 2026 | 59.09M |
| August 12, 2026 | 46.35M |
| August 11, 2026 | 43.17M |
| August 10, 2026 | 39.98M |
| August 07, 2026 | 36.80M |
| August 06, 2026 | 29.37M |
| August 05, 2026 | 25.12M |
| August 04, 2026 | 29.37M |
| August 03, 2026 | 25.12M |
| July 31, 2026 | 23.00M |
| July 30, 2026 | 23.00M |
| July 29, 2026 | 18.76M |
| July 28, 2026 | 23.00M |
| July 27, 2026 | 19.82M |
| July 24, 2026 | 26.19M |
| July 23, 2026 | 30.43M |
| July 22, 2026 | 32.55M |
| July 21, 2026 | 42.11M |
| July 20, 2026 | 35.74M |
| July 17, 2026 | 43.17M |
| July 16, 2026 | 54.84M |
| July 15, 2026 | 62.27M |
| July 14, 2026 | 62.27M |
| July 13, 2026 | 58.03M |
| July 10, 2026 | 52.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 46.31B |
| Bio-Rad Laboratories, Inc. | 9.815B |
| Bruker Corp. | 11.01B |
| Azenta, Inc. | 1.180B |
| Danaher Corp. | 172.40B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.874M |
| Revenue (Quarterly) | 7.271M |
| Total Expenses (Quarterly) | 16.14M |
| EPS Diluted (Quarterly) | -0.0831 |
| Gross Profit Margin (Quarterly) | 63.86% |
| Profit Margin (Quarterly) | -122.0% |
| Earnings Yield | -27.26% |
| Normalized Earnings Yield | -22.13 |